Preissner K T, Sié P
Clinical Research Unit for Blood Coagulation and Thrombosis, Max-Planck-Gesellschaft, Justus-Liebig-Universität Giessen, FRG.
Thromb Haemost. 1988 Dec 22;60(3):399-406.
The complement inhibitor S protein, which is identical to the adhesive protein vitronectin, functions as heparin-neutralizing factor by protecting thrombin as well as factor Xa against fast inactivation by antithrombin III. The interference of S protein with glycosaminoglycan-catalyzed inhibition of thrombin by heparin cofactor II was investigated in these studies. S protein significantly counteracted the anticoagulant activity of heparin and pentosan polysulfate but not of dermatan sulfate. In the presence of 0.3 micrograms/ml heparin, 0.5 micrograms/ml pentosan polysulfate, or 2 micrograms/ml dermatan sulfate, S protein induced a concentration-dependent reduction of the inhibition rate of thrombin by heparin cofactor II. This resulted in a decrease of the apparent pseudo first-order rate constants by about 17-fold (heparin), or about 7-fold (pentosan polysulfate), whereas no neutralization of dermatan sulfate was demonstrable at a physiological ratio of S protein to heparin cofactor II. Exposure of the glycosaminoglycan-binding region of S protein by reduction and carboxymethylation of the protein increased the neutralizing activity of S protein towards heparin and pentosan polysulfate. The results of these functional experiments correlated well with the demonstration of direct binding of S protein to both polysaccharides but not to dermatan sulfate. While reduced/carboxymethylated S protein remained also ineffective in neutralizing other dermatan sulfate compounds with varying degree of sulfation, a synthetic highly basic tridecapeptide, representing a portion of the glycosaminoglycan-binding domain of S protein, counteracted their anticoagulant activity.(ABSTRACT TRUNCATED AT 250 WORDS)
补体抑制剂S蛋白与黏附蛋白玻连蛋白相同,它通过保护凝血酶和Xa因子不被抗凝血酶III快速灭活而发挥肝素中和因子的作用。在这些研究中,对S蛋白干扰肝素辅因子II介导的糖胺聚糖催化的凝血酶抑制作用进行了研究。S蛋白能显著抵消肝素和戊聚糖多硫酸盐的抗凝活性,但对硫酸皮肤素则无此作用。在存在0.3微克/毫升肝素、0.5微克/毫升戊聚糖多硫酸盐或2微克/毫升硫酸皮肤素的情况下,S蛋白可诱导肝素辅因子II对凝血酶抑制率的浓度依赖性降低。这导致表观假一级速率常数降低约17倍(肝素)或约7倍(戊聚糖多硫酸盐),而在S蛋白与肝素辅因子II的生理比例下,未显示硫酸皮肤素有中和作用。通过对S蛋白进行还原和羧甲基化处理,使其糖胺聚糖结合区域暴露,可增强S蛋白对肝素和戊聚糖多硫酸盐的中和活性。这些功能实验的结果与S蛋白直接结合这两种多糖而不结合硫酸皮肤素的结果密切相关。虽然还原/羧甲基化的S蛋白在中和不同硫酸化程度的其他硫酸皮肤素化合物时也无效,但一种代表S蛋白糖胺聚糖结合域一部分的合成高碱性十三肽可抵消它们的抗凝活性。(摘要截短至250字)